CMS assigns Q codes to procedures, services, and supplies on a temporary basis. When a permanent code is assigned, the Q code is deleted and cross-referenced.
High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml
High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml
High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml
High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg
Continued
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose
Injection, ferric carboxymaltose, 1mg
Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
Injection, epoetin beta, 1 microgram, (non-esrd use)
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
Injection, factor viii fc fusion protein (recombinant), per iu
Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron
Compounded drug, not otherwise classified
Netupitant 300 mg and palonosetron 0.5 mg
Injection, alemtuzumab, 1 mg
Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg
Rolapitant, oral, 1 mg
Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg
Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
Injection, hydroxyprogesterone caproate, (makena), 10 mg
Pathogen(s) test for platelets
Platelets, pheresis, pathogen-reduced, each unit
Ustekinumab, for intravenous injection, 1 mg
Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg
Injection, buprenorphine extended-release (sublocade), greater than 100 mg
Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
In-line cartridge containing digestive enzyme(s) for enteral feeding, each
Injection, emicizumab-kxwh, 0.5 mg
Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg
Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg
Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg
Injection, ustekinumab-aauz (otulfi), biosimilar, 1 mg